Printer Friendly
The Free Library
14,815,112 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks Buy List Highlights: Hittite Microwave Corporation, PACCAR, Inc., Tidewater, Inc. and Sciele Pharma, Inc.


CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today are Hittite Microwave Corporation (Nasdaq: HITT HITT Heparin-induced thrombocytopenia/thrombosis, see there ), PACCAR PACCAR Pacific Car and Foundry Company (former railroad car manufacturer now parent corp of Peterbilt & Kenworth Truck) , Inc. (Nasdaq: PCAR PCAR Pennsylvania Coalition Against Rape
PCAR Post Contract Award Review
), Tidewater tidewater, in U.S. history, that part of the Atlantic coastal plain between the shoreline and the farthest upstream points in rivers reached by oceanic tides. In many cases the fall line is given as the western boundary. , Inc. (NYSE NYSE

See: New York Stock Exchange
: TDW TDW Total Diamond Weight
TDW Telecommunications Data Warehouse
TDW Tower Display Workstation (FAA)
TDW Tonnage Dead Weight
TDW Training Development Workload
TDW Time/Data Word
TDW Turbo Debugger for Windows
), and Sciele Pharma, Inc. (Nasdaq: SCRX).

Stocks ranked #1 (Strong Buy) by Zacks have produced an average annual return of +31.8% since inception in 1988. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8% while the S&P 500 tumbled 37.6%. To see the full Zacks #1 Rank (Strong Buy) List, or the rank for any other stock, visit: http://at.zacks.com/?id=88

Here is a synopsis of today's Zacks Rank Buy Stocks:

Aggressive Growth - Hittite Microwave Corporation (Nasdaq: HITT)

Hittite Microwave Corporation is in a sweet spot in the semiconductor industry. The company has comfortably exceeded earnings estimates in seven straight quarters. Five analysts have raised their estimates for this year. Over the past week, this year's earnings estimates have increased six cents to $1.56 per share, while next year's numbers have risen seven cents to $1.69 per share.

Growth & Income - PACCAR, Inc. (Nasdaq: PCAR)

PACCAR, Inc. has returned more than 43% since it was last highlighted as a Growth and Income stock on Oct 26. The company is still a Zacks #1 Rank stock due to its strong history of exceeding the Street's earnings expectations coupled with rising profit forecasts. The Board of Directors recently approved an increase of the regular quarterly dividend to 25 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
 from 20 cents. PCAR has a current dividend yield of 0.94%.

Momentum - Tidewater, Inc. (NYSE: TDW)

On Apr 26, Tidewater, Inc. reported fiscal fourth-quarter earnings of $1.56 per share, up from $1.11 in the prior-year quarter and nine cents above expectations. Tidewater has exceeded analysts' estimates by an average of 8.1% over the last 10 consecutive quarters. In response to the latest earnings report, TDW rose to record highs on strong volume.

Value - Sciele Pharma, Inc. (Nasdaq: SCRX)

Sciele Pharma, Inc. met or beat analysts' earnings expectations in 15 out of the past 16 quarters. After reporting solid first-quarter results, the company raised its full-year revenue and profit guidance. Analysts have been upping their profit forecasts as a result. SCRX recently announced it will acquire Alliant Pharmaceuticals, Inc. The company has a price-to-book ratio of 2.2 and its PEG ratio PEG Ratio

See: Prospective earnings growth ratio


PEG ratio

See price-earnings/growth ratio (PEG ratio).
 currently sits at 0.56.

Truly taking advantage of the Zacks Rank requires the understanding of how it works.

The free special report, "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions," provides an insightful background about this wealth-building tool. Download your free copy of the report now to prosper in the years to come by visiting http://at.zacks.com/?id=93.

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." A $10,000 investment in the Zacks Rank list made in 1988 would now be worth $1.77 million - equivalent to a 31.8% annualized annualized

Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared.
 return! During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8%, while the S&P 500 tumbled 37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 143.6% annually (+4.8% vs. +11.8%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day"
subscribe, take

buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company";
 this free newsletter today by visiting http://at.zacks.com/?id=90.

About Zacks

Zacks.com is a property of Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=91

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment Reinvestment

Using dividends, interest and capital gains earned in an investment or mutual fund to purchase additional shares or units, rather than receiving the distributions in cash.

1. In terms of stocks, it is the reinvestment of dividends to purchase additional shares.
 of all dividends, no transaction costs Transaction Costs

Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it).
, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 to buy or sell any security.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 3, 2007
Words:898
Previous Article:Fraunhofer IIS: Radio Classique selects mp3 Surround for 5.1 surround sound Internet radio.
Next Article:International Electronics, Inc. Recommends Rejection of Revised Offer from Risco Ltd.
Topics:



Related Articles
Zacks Issues Buy Recommendations on the Following 4 Stocks: Amer. Pharma Partners, Fresh Del Monte, PACCAR, AmerisourceBergen, MetLife and OmniVision.
Zacks Buy List Highlights: PACCAR, Resources Connection, Amgen, and Quiksilver.
Zacks Analyst Blog Highlights: Advance Auto Parts and Sciele Pharma.
Jerry C. Griffin, M.D. Joins Sciele Pharma Board of Directors.(Company overview)
Zacks Buy List Highlights: Illumina, Inc., PACCAR, Inc., Snap-on Incorporated and Reliance Steel & Aluminum Co.
Sciele Pharma to Present at the Piper Jaffray Health Care Conference.
Dr. John Kapoor Retires from Sciele Pharma Board of Directors.
Sciele Pharma to Present at the JPMorgan 25th Annual Healthcare Conference.
Zacks Bull and Bear of the Day Highlights: Hittite Microwave, Enzon Pharmaceuticals, Con-way and Pride International.
Zacks Buy List Highlights: Sciele Pharma, Inc., The Boeing Company, ZOLL Medical Corporation and Imperial Sugar Company.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles